Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
12.86B | 12.98B | 13.06B | 13.18B | 12.34B | 11.51B | Gross Profit |
4.76B | 4.78B | 4.71B | 4.85B | 4.50B | 4.18B | EBIT |
659.00M | 580.00M | 840.00M | 1.06B | 918.00M | 665.00M | EBITDA |
907.00M | 1.25B | 1.32B | 1.71B | 1.47B | 835.00M | Net Income Common Stockholders |
345.00M | 345.00M | 471.00M | 843.00M | 592.00M | 8.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
229.00M | 360.00M | 286.00M | 823.00M | 1.14B | 790.00M | Total Assets |
11.85B | 11.90B | 12.10B | 12.35B | 12.27B | 11.91B | Total Debt |
176.00M | 2.48B | 2.56B | 2.39B | 2.52B | 3.26B | Net Debt |
-53.00M | 2.12B | 2.28B | 1.57B | 1.38B | 2.47B | Total Liabilities |
5.70B | 5.30B | 5.44B | 5.57B | 5.70B | 6.11B | Stockholders Equity |
6.15B | 6.60B | 6.66B | 6.78B | 6.57B | 5.80B |
Cash Flow | Free Cash Flow | ||||
1.06B | 954.00M | 368.00M | 752.00M | 1.35B | 531.00M | Operating Cash Flow |
1.41B | 1.32B | 824.00M | 1.16B | 1.63B | 876.00M | Investing Cash Flow |
-344.00M | -356.00M | -441.00M | -389.00M | -213.00M | -152.00M | Financing Cash Flow |
-910.00M | -898.00M | -938.00M | -1.01B | -536.00M | -722.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | £4.32B | 13.09 | 5.22% | 5.00% | -2.09% | 6.71% | |
67 Neutral | £1.38B | 20.85 | 16.11% | 3.10% | 6.97% | -14.59% | |
60 Neutral | $13.01B | 10.45 | 0.79% | 3.53% | 1.60% | -22.47% | |
47 Neutral | £390.49M | ― | -14.20% | 8.22% | -5.98% | -677.54% |